Skip to main content

Table 2 Design of the experiment: parameters per role and round

From: Assessing social preferences in reimbursement negotiations for new Pharmaceuticals in Oncology: an experimental design to analyse willingness to pay and willingness to accept

   

Deciders

Receiver

Funders

Regulator

Seller

Patient

Payers

Investors

Treatment option

Round

Reservation pricea

Benefita,b

Benefita,b

Survival (m)

Quality of Life (q)

Benefita

Benefita

Benefita

No treatment

    

0

50%

0

  

Standard treatment (SoC)

0

50

120

120

5

50%

25

240 - x

x

New treatment option

1

x

120

120

8

50%

40

240 - x

x

2

x

120

120

10

50%

50

240 - x

x

3

x

120

120

12

50%

60

240 - x

x

4

x

120

120

15

50%

75

240 - x

x

5

x

120

120

17

50%

85

240 - x

x

  1. Table adapted from Wettstein/Boes 2020 [33]
  2. SoC standard of care (status quo), m survival in months, q quality of life on a scale of 1–100%
  3. afor groups 1 to 4, amounts displayed in thousands $ (converted 100,000 $ = 1 US$ at end of the experiment); for groups 5 to 6, amounts divided by 100 and displayed in $ (converted 1 $ = 1 US$ at end of the experiment)
  4. badditional bonus for participating in training in run one and for successful offer in run two (game not covered in this publication)